Enter multiple symbols separated by commas

Abbott Profit Declines 19% As Charges Offset Higher Sales

Abbott Laboratories said on Wednesday its first-quarter earnings fell 19% as charges related to acquisitions and cost-cutting offset sharply higher sales of its prescription drugs and medical devices.

Shares fell , but results topped the average Wall Street forecast, making Abbott the fourth largest U.S. drugmaker this month to report earnings above analysts' estimates.

Excluding special items, Abbott earned 55 cents a share.

Analysts surveyed by Thomson Financial predicted a profit of 52 cents a share with sales of $5.26 billion.

Net earnings were $697.5 million, or 45 cents a share, down from $865 million, or 56 cents a share, in the year-earlier period.

Abbott's sales jumped almost 16% to $5.3 billion, a tad higher than Wall Street forecasts, helped by new products from acquisitions and favorable foreign exchange factors.

Prescription drug revenue rose almost 17% to $3.37 billion as its injectable Humira treatment for rheumatoid arthritis continued to grow by leaps and bounds, and drugs to raise "good" HDL cholesterol, acquired in a recent merger, continued to help results.

Sales of Humira, which targets the same inflammatory protein as Wyeth's Enbrel and Johnson & Johnson's Remicade, rose 46% to $571 million.

Abbott slightly raised its 2007 earnings forecast, to a range of $2.79 to $2.85 per share, citing higher-than-expected revenue in the first quarter from its TAP joint venture with Takeda Pharmaceutical Co.

Contact U.S. News


    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Don't Miss

  • Mark Cuban and Donald Trump

    Donald Trump appears to have Mark Cuban's vote, at least in terms of how the billionaire real estate mogul is conducting his political campaign.

  • Ferrari 488 Spider

    Ferrari's new 488 Spider will have a V-8 turbo engine and a retractable hard-top roof that lowers in just 14 seconds.

  • Members of the New Horizons science team react to seeing the spacecraft's last and sharpest image of Pluto before closest approach later in the day at the Johns Hopkins University Applied Physics Laboratory (APL) in Laurel, Maryland July 14, 2015.More than nine years after its launch, a U.S. spacecraft sailed past Pluto on Tuesday, capping a 3 billion mile (4.88 billion km) journey to the solar system's farthest reaches, NASA said.

    The New Horizons Pluto flyby mission set records for NASA's social media and web metrics——but why do we care so much?

U.S. Video

  • Wall Street awaits Fed, snaps losing streak

    The stock market has broken its five-session losing streak, but the fate of today's trading will likely rest in the hands of the Fed, which releases its post-meeting policy statement this afternoon.

  • Delivering Alpha unfiltered: Global Opportunity

    Complete video of Andrew Ross Sorkin's panel on how to navigate the wide array of global investment challenges that investors face featuring Chris Ailman, Mary Callahan Erdoes, Eric Mindich and Richard Perry.

  • Cramer: Signs point to another rally

    Mad Money host Jim Cramer shares his view of the market rally in Tuesday's trading session. Finally we have a good setup, he says.